By most accounts, 2021 was another memorable year for Korea’s medical and biopharmaceutical industries. The nation continued to see the Covid-19 virus spread throughout the country, while the emergence of variants hindered activities from curbing the spread of the virus.

While the fight against the epidemic is still going on and its impact is causing various social and economic difficulties seldom seen before, the roll-outs of vaccines and treatments for Covid-19 helped the country prevent the situation from going out of the control.

To give our readers a quick grasp of what drew their interests most, Korea Biomedical Review has compiled 20 news visited most by readers.

Since every reader has a different interest and priority, the selected news might not cover some of our readers’ favorites. If so, please mention which article should have been chosen in the comment section below. – Ed.